Trade Mark Journal No.2021/053 31 December 2021
WO0000001629650 (1,5,42)
Office of origin: European Union Intellectual Property Office (EUIPO)
Date of International Registration:22 October 2021
Date of designation in the UK:
22 October 2021

International priority date claimed: 20 May 2021
(European Union Intellectual Property Office (EUIPO))
(018475345)
- Class 1
- Chemical preparations; molecules for use in industry; molecules for use in science; molecules for molecular biology, other than for medical or veterinary use.
- Class 5
- Pharmaceutical and therapeutic preparations for the treatment of cancer, immunological diseases, inflammatory diseases, neurological diseases, and genetic disorders; pharmaceutical and therapeutic preparations for modulating protein degradation pathways.
- Class 42
- Scientific research and development services; research of protein degradation; discovery and development of protein degradation pathway modulating molecules; research of protein ubiquitination; discovery and development of proximity-inducing agents; research and development of proteolysis targeting chimeras; research and development of ligase-mediated protein modifications; discovery and development of molecular glue degraders; discovery and development of monovalent protein degraders.
Proxygen GmbH
Representative: MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH, Elisenhof Elisenstr. 3, 80335 München, GERMANY